| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1739 | 2020 |
| Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model M Li, VO Ona, C Guégan, M Chen, V Jackson-Lewis, LJ Andrews, ... Science 288 (5464), 335, 2000 | 857 | 2000 |
| Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database AJ Olszewski, JJ Castillo Cancer 119 (3), 629-638, 2013 | 210 | 2013 |
| Epidemiology and survival outcomes of ocular and mucosal melanomas: A population‐based analysis KD Bishop, AJ Olszewski International journal of cancer 134 (12), 2961-2971, 2014 | 192 | 2014 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 166 | 2021 |
| Outcomes of patients with double-hit lymphoma who achieve first complete remission DJ Landsburg, MK Falkiewicz, J Maly, KA Blum, C Howlett, T Feldman, ... Journal of Clinical Oncology 35 (20), 2260, 2017 | 157 | 2017 |
| Sites of extranodal involvement are prognostic in patients with diffuse large B‐cell lymphoma in the rituximab era: an analysis of the surveillance, epidemiology and end … JJ Castillo, ES Winer, AJ Olszewski American journal of hematology 89 (3), 310-314, 2014 | 154 | 2014 |
| Overall survival and competing risks of death in patients with W aldenström macroglobulinaemia: an analysis of the S urveillance, E pidemiology and E nd R esults database JJ Castillo, AJ Olszewski, S Kanan, K Meid, ZR Hunter, SP Treon British Journal of Haematology 169 (1), 81-89, 2015 | 140 | 2015 |
| Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) cohort study DR Rivera, S Peters, OA Panagiotou, DP Shah, NM Kuderer, CY Hsu, ... Cancer discovery 10 (10), 1514-1527, 2020 | 139 | 2020 |
| Extranodal diffuse large B cell lymphoma: molecular features, prognosis, and risk of central nervous system recurrence TA Ollila, AJ Olszewski Current treatment options in oncology 19, 1-20, 2018 | 129 | 2018 |
| Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis H Shafqat, S Ali, M Salhab, AJ Olszewski Diseases of the Colon & Rectum 58 (3), 294-303, 2015 | 112 | 2015 |
| Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base AJ Olszewski, R Shrestha, JJ Castillo Journal of Clinical Oncology 33 (6), 625-633, 2015 | 97 | 2015 |
| Survival trends in Waldenström macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results database JJ Castillo, AJ Olszewski, AM Cronin, ZR Hunter, SP Treon Blood, The Journal of the American Society of Hematology 123 (25), 3999-4000, 2014 | 89 | 2014 |
| Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia TW LeBlanc, PC Egan, AJ Olszewski Blood, The Journal of the American Society of Hematology 132 (7), 717-726, 2018 | 81 | 2018 |
| Population‐based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database JJ Castillo, ES Winer, AJ Olszewski Cancer 119 (20), 3672-3679, 2013 | 78 | 2013 |
| Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers AM Evens, A Danilov, D Jagadeesh, A Sperling, SH Kim, R Vaca, C Wei, ... Blood, The Journal of the American Society of Hematology 137 (3), 374-386, 2021 | 74 | 2021 |
| Antibody response to COVID-19 vaccination in adults with hematologic malignant disease TA Ollila, S Lu, R Masel, A Zayac, K Paiva, RD Rogers, AJ Olszewski JAMA oncology 7 (11), 1714-1716, 2021 | 69 | 2021 |
| Adjuvant therapy for resected gallbladder cancer: analysis of the National Cancer Data Base KC Mantripragada, F Hamid, H Shafqat, AJ Olszewski Journal of the National Cancer Institute 109 (2), djw202, 2017 | 68 | 2017 |
| Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma JJ Castillo, T Guerrero-Garcia, F Baldini, E Tchernonog, G Cartron, ... British journal of haematology 184 (4), 679-682, 2019 | 66 | 2019 |
| Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma TA Ollila, I Sahin, AJ Olszewski OncoTargets and therapy 12, 1085, 2019 | 60 | 2019 |
Jorge CastilloHarvard Medical SchoolVerified email at dfci.harvard.edu
